【レポートの概要（一部）】
1. Introduction to Cancer Immunotherapy
2. Classification of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.2 Non-Specific Cancer Immunotherapy
3. Cancer Immunotherapy by Vaccines
3.1 Introduction
3.2 Mechanism of Vaccines in Cancer Immunotherapy
3.2.1 Idiotype Cancer Vaccine Mechanism
3.2.2 Cellular Cancer Vaccines Mechanism
3.2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
3.2.4 Peptide Cancer Vaccine Mechanism
3.2.5 Tumor Host Interaction Cancer Vaccine Mechanism
4. Cancer Immunotherapy by Monoclonal Antibodies
4.1 Introduction
4.2 Mechanism of Monoclonal Antibodies in Cancer Immunotherapy
5. Cancer Immunotherapy by Adoptive Cell Transfer
5.1 Introduction
5.2 Mechanism of Adoptive Cell Transfer Cancer Immunotherapy
6. Cancer Immunotherapy by Immune Checkpoint Inhibitors
6.1 Introduction
6.2 Mechanism of Immune Checkpoint Inhibitors in Cancer Immunotherapy
7. Cancer Immunotherapy by Immunomodulators
7.1 Introduction
7.2 Mechanism of Immunomodulators in Cancer Immunotherapy
8. Cancer Immunotherapy by Cytokines
8.1 Introduction
8.2 Mechanism of Cytokines Cancer Immunotherapy
9. Cancer Immunotherapy by Interleukins
9.1 Introduction
9.2 Mechanism of Interleukinsin Cancer Immunotherapy
10. Cancer Immunotherapy by Interferon
10.1 Introduction
10.2 Mechanism of Interferon Cancer Immunotherapy
11. Cancer Immunotherapy by GM-CSF
11.1 Introduction
11.2 Mechanism of GM-CSF Cancer Immunotherapy
12. Cancer Immunotherapy Market Overview
12.1 Current Market Scenario
12.2 Cancer Immunotherapy Pipeline Overview
13. Global Cancer Immunotherapy Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges
14. Global Cancer Immunotherapy Market Future Prospects
15. Cancer Cell Therapies Clinical Pipeline by Company, Indication & Phase
15.1 Unknown
15.2 Research
15.3 Preclinical
15.4 Clinical
15.5 Phase-I
15.6 Phase-I/II
15.7 Phase-II
15.8 Phase-III
15.9 Preregistration
16. Marketed Cancer Cell Therapies Drugs Clinical Insight
16.1 Sipuleucel-T (Provenge®)
16.2 T-Lymphocyte Cell Therapy(Immuncell-LC®)
17. Cancer Cytokines Clinical Pipeline by Company, Indication & Phase
17.1 Unknown
17.2 Research
17.3 Preclinical
17.4 Clinical
17.5 Phase-I
17.6 Phase-I/II
17.7 Phase-II
17.8 Phase-III
18. Marketed Cancer Cytokines Drugs Clinical Insight
18.1 Aldesleukin (Proleukin®)
18.2 Denileukin Diftitox (ONTAK®)
18.3 Interferon Alpha (Multiferon®)
18.4 Interferon Alpha-2a (Roferon-A®)
18.5 Interferon Alpha-2a (Veldona®)
18.6 Interferon Alpha-2a Biosimilar(Inferon™/Inmutag™)
18.7 Interferon Alpha-2b(Intron® A)
18.8 Interferon Alpha-2b Biosimilar(Bioferon™)
18.9 Interferon Alpha-2b Biosimilar (Intalfa®)
18.10 Interferon Alpha-2b Biosimilar
18.11 Interferon-Alpha-n3 (Alferon N®)
18.12 Interferon-Beta-1b (Feron®)
18.13 Interferon-Gamma (Ogamma®)
18.14 Interleukin-2 Biosimilar (Ilcass)
18.15 Teceleukin (Imunace™)
19. Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase
19.1 Unknown
19.2 Research
19.3 Preclinical
19.4 Clinical
19.5 Phase-I
19.6 Phase-I/II
19.7 Phase-II
19.8 Phase-II/III
19.9 Phase-III
19.10 Preregistration
19.11 Registered
20. Marketed Cancer Immunomodulators Clinical Insight
21. Cancer Vaccine Clinical Pipeline By Company, Indication & Phase
21.1 Research
21.2 Preclinical
21.3 Clinical
21.4 Phase-I
21.5 Phase-I/II
21.6 Phase-II
21.7 Phase-II/III
21.8 Phase-III
21.9 Preregistration
21.10 Registered
22. Marketed Cancer Vaccines Clinical Insight
22.1 Bladder Cancer Vaccine (PACIS®)
22.2 Bladder Cancer Vaccine
22.3 BV NSCLC 001
22.4 Dendritic Cell Vaccine (CreaVax-HCC®, CreaVax-PC® & CreaVax-RCC®)
22.5 Human Papillomavirus Vaccine Quadrivalent (Gardasil®/Silgard®)
22.6 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarix®)
22.7 Melanoma Vaccine (MVax®)
22.8 Melanoma Vaccine (Melacine®)
22.9 Racotumomab (Vaxira®)
22.10 Sipuleucel-T (Provenge®)
22.11 Tertomotide (LucaVax)
22.12 Vitespen (Oncophage®)
23. Cancer Monoclonal Antibodies Clinical Pipeline by Company, Indication & Phase
23.1 Unknown
23.2 Research
23.3 Preclinical
23.4 Clinical
23.5 Phase-I
23.6 Phase-I/II
23.7 Phase-II
23.8 Phase-II/III
23.9 Phase-III
23.10 Preregistration
23.11 Registered
24. Marketed Cancer Monoclonal Antibodies Drugs Clinical Insight
25. Competitive Landscape
25.1 Abbvie
25.2 Advaxis
25.3 Altor BioScience
25.4 Amgen
25.5 Biogen Idec
25.6 Biogenomics
25.7 Celldex Therapeutics
25.8 Dendreon Corporation
25.9 Eli Lilly
25.10 Expression Genetics
25.11 Galena Biopharma
25.12 Genmab
25.13 Gilead Sciences
25.14 GlaxoSmithKline
25.15 ImmunoCellular Therapeutics
25.16 ImmunoGen
25.17 Inovio Pharmaceuticals
25.18 IRX Therapeutics
25.19 Merck
25.20 NeoStem Oncology
25.21 NewLink Genetics
25.22 Northwest Biotherapeutics
25.23 Novartis
25.24 Peregrine Pharmaceuticals
25.25 Pfizer
25.26 Philogen
25.27 Regulon
25.28 Roche
25.29 Seattle Genetics
25.30 ZymoGenetics
【レポート販売概要】
■ タイトル：癌免疫療法の世界市場動向■ 英文：Global Cancer Immunotherapy Market Outlook 2020
■ 発行日：2015年6月
■ 調査会社：KuicK Research
■ 商品コード：KUIK506192
■ 調査対象地域：グローバル
- 世界のトランスフェクション試薬＆機器市場：製品別、地域別Global Transfection Reagents and Equipment Market: About this market Technavio’s transfection reagents and equipment market analysis considers sales from both reagents and equipment products. Our study also finds the sales of transfection reagents and equipment in Asia, Europe, North America, and ROW. In 2019, the reagents segment had a significant market share, and this trend is expected to conti …
- 世界のポリウレタン・フォウム市場動向（2014～2018）TechNavio's analysts forecast the Global Polyurethane Foam market to grow at a CAGR of 7.03 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand from Bedding & Furniture and Construction industries. The Global Polyurethane Foam market has also been witnessing the introduction of green polyurethane foam. However, the increasing prices …
- 可変周波数駆動装置（VFD）の世界市場2015-2022According to Stratistics MRC, the Global Variable Frequency Drives (VFD) market is accounted for $18.12 billion in 2015 and is expected to reach $34.36 billion by 2022 growing at a CAGR of 9.5% during the forecast period. Increase in demand, price of the electricity, enlarging usage of variable frequency drives and following the best energy efficiency standards in manufacturing VFD are the major f …
- Belviq（肥満治療薬）：市場予測及び分析（～2022）Belviq (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molec …
- 写真素材の世界市場2015-2019About Still Images Still image refers to any static image. Still image API is a standardized interface that is used for obtaining digital still images from devices such as flatbed scanner, handheld scanner, and still-image digital camera. Still images are captured using two models: pull and push. Still images are developed by C and C++ programmers for the users. It is predominantly used in newspap …
- 世界のベータカロテン（Beta-Carotene）市場動向及びインサイトProduct Synopsis This forecast and market trend report on Beta-Carotenes covers an in-depth analysis of Beta- Carotenes ingredientss manufacturers and ingredientss products characteristics in relation to raw material use and extraction methods. The report investigates health benefits of Beta- Carotenes and its regulatory status. The use for this ingredients category for food and beverage products …
- 世界小売産業におけるビデオ監視市場動向（2012-2016）TechNavio's analysts forecast the Global Intelligent Video Surveillance market in the Retail industry to grow at a CAGR of 27.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for better image quality. The Global Intelligent Video Surveillance market in the Retail industry has also been witnessing the increasing adoption of IP …
- 若年性骨髄単球性白血病（JMML）：世界の臨床試験レビュー（2014年上半期）Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Juvenile Myelomonocytic Leukemia (JMML) Global Clinical Trials Review, H1, 2014" provides data on the Juvenile Myelomonocytic Leukemia (JMML) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Juvenile Myelomonocyt …
- バイオコハク酸の世界市場2019-2023About this market The increasing focus on the sustainable use of natural resources, the demand for bio-based or renewable chemicals is rising at a rapid rate. As bio-succinic acid is derived from natural resources, it is used as a replacement for building blocks such as adipic acid and phthalic anhydride, which are used to manufacture compounds such as polyols. The chemical composition of bio-succ …
- ジャイロ・カメラの世界市場2017-2021ABSTRACTAbout Gyro Cameras Gyro cameras are used to capture extreme action sports or activities. Regular cameras are incapable of capturing high-speed actions and are not designed for rugged conditions, including extreme weather. Gyro cameras are compact, lightweight, designed for rugged conditions, and can be worn on the person or are mountable on vehicles. These cameras can capture high-speed ac …
- 世界の先進CO2センサー市場2015The Global Advanced CO2 Sensors Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Advanced CO2 Sensors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Advanced CO2 Sensors market analysis is provided for the international markets including develop …
- スマート発券の世界市場予測（～2022）：製品別 (発券機、Eチケット、Eキオスク）、構成要素別、システム別、用途別、地域別According to the MarketsandMarkets forecast, the smart ticketing market is expected be worth USD 10.22 Billion by 2022, growing at a CAGR of 7.93% between 2016 and 2022. The major drivers for the market include affordable access to smart transit system, emerging application travel and tourism industry, flourishing adoption of smart technology, and user-friendly platform. The report covers the smar …
- German HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Commercial Labs–Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT ProceduresComplete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in Germany. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals &nbs …
- グローバルスマートフォン市場動向Product Synopsis Emerging Markets Will Generate 58% of Smartphone Sales in 2012-2017 Smartphone Research in Focus Q2 2013 More than half of the world's smartphones were sold in emerging markets in 2012. Globally, smartphone unit sales grew at a CAGR of 52.7% between 2008 and 2012, reaching 641m. Looking forward, smartphone sell-through will increase at a CAGR of 18.3% through 2017, reaching 1.5bn …
- 世界の食品用潤滑剤市場2015The Global Food Grade Lubricants Industry Report 2015 is a professional and in-depth study on the current state of the Food Grade Lubricants industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Food Grade Lubricants market analysis is provided for the international markets including development trends, …
